摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[(4-氯苯基)氨基]-3-氧代丙酸乙酯 | 15386-84-2

中文名称
3-[(4-氯苯基)氨基]-3-氧代丙酸乙酯
中文别名
——
英文名称
ethyl 3-(4-chloroanilino)-3-oxopropionate
英文别名
ethyl 3-[(4-chlorophenyl)amino]-3-oxopropanoate;ethyl 3-(4-chlorophenylamino)-3-oxo-propanoate;N-(4-chlorophenyl)malonamic acid ethyl ester;ethyl N-(4-chlorophenyl)-carbamoylacetate;N-(4-chloro-phenyl)-malonamic acid ethyl ester;N-(4-Chlor-phenyl)-malonamidsaeure-aethylester;ethyl 3-(4-chloroanilino)-3-oxopropanoate
3-[(4-氯苯基)氨基]-3-氧代丙酸乙酯化学式
CAS
15386-84-2
化学式
C11H12ClNO3
mdl
MFCD02317188
分子量
241.674
InChiKey
NEGQZYYDIHYHMQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    97 °C
  • 沸点:
    412.2±30.0 °C(Predicted)
  • 密度:
    1.289±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    16
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.272
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:1a1aeb09a8fc93c4a54ba0814e93f9f6
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Diamine derivatives
    申请人:Ohta Toshiharu
    公开号:US20050020645A1
    公开(公告)日:2005-01-27
    A compound represented by the general formula (1): Q 1 -Q 2 -T 0 -N(R 1 )-Q 3 -N(R 2 )-T 1 -Q 4 (1) wherein R 1 and R 2 are hydrogen atoms or the like; Q 1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q 2 is a single bond or the like; Q 3 is a group in which Q 5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T 0 and T 1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
    通用式(1)表示的化合物: Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4(1) 其中R1和R2是氢原子或类似物;Q1是饱和或不饱和的、5-或6-成员环烃基,可以被取代,或类似物;Q2是单键或类似物;Q3是一个基团,其中Q5是具有1至8个碳原子的烷基基团,或类似物;T0和T1是羰基团或类似物;其盐、溶剂合物或N-氧化物。 该化合物可用作预防和/或治疗脑梗死、脑栓塞、心肌梗死、心绞痛、肺梗死、肺栓塞、布尔格病、深静脉血栓形成、弥散性血管内凝血综合征、瓣膜或关节置换后的血栓形成、血管成形术后的血栓形成和再闭塞、全身性炎症反应综合征(SIRS)、多器官功能障碍综合征(MODS)、体外循环期间的血栓形成,或抽血时的血液凝结。
  • Acetohydroxamic acids
    申请人:Laboratoire L. Lafon
    公开号:US04122186A1
    公开(公告)日:1978-10-24
    The invention provides new acetohydroxamic acid derivatives, having interesting properties on the central nervous system, of the formula: R.sub.1 R.sub.2 R.sub.3 C-CO-NHOH, in which R.sub.2 and R.sub.3 are each hydrogen or C.sub.1-6 alkyl, and R.sub.1 is C.sub.1-6 alkyl Z.sub.1 Z.sub.2 N (where Z.sub.1 and Z.sub.2 are each phenyl, substituted phenyl, or cycloalkyl), substituted hydantoinyl, benzhydroxylcarboxamido, Z.sub.3 CH.sub.2 -- (where Z.sub.3 = optionally substituted aryl), Z.sub.4 -A- (where Z.sub.4 is optionally substituted phenyl or naphthyl, and A is --NH--, --N(C.sub.1-4 alkyl)--, --N(C.sub.5-6 cycloalkyl)--, --NHCO--, --N(C.sub.1-4 alkyl)CO--, --N(C.sub.5-6 cycloalkyl)CO--, --CONH--, --CON(C.sub.1-4 alkyl)--, --CON(C.sub.5-6 cycloalkyl)--, --NHCONH--, --N(C.sub.5 H.sub.6)CONH--, or --N(substituted phenyl)CONH--, optionally substituted benzimidazolyl, or an optionally substituted tricyclic radical, and their metal and acid addition salts.
    该发明提供了新的乙酰羟羟胺酸衍生物,具有对中枢神经系统有趣的性质,其化学式为:R.sub.1 R.sub.2 R.sub.3 C-CO-NHOH,其中R.sub.2和R.sub.3分别为氢或C.sub.1-6烷基,R.sub.1为C.sub.1-6烷基Z.sub.1 Z.sub.2 N(其中Z.sub.1和Z.sub.2分别为苯基、取代苯基或环烷基)、取代咪唑烷基、苯羟基羧酰胺基、Z.sub.3 CH.sub.2-(其中Z.sub.3=可选择取代芳基)、Z.sub.4-A-(其中Z.sub.4为可选择取代苯基或萘基,A为--NH--、--N(C.sub.1-4烷基)--、--N(C.sub.5-6环烷基)--、--NHCO--、--N(C.sub.1-4烷基)CO--、--N(C.sub.5-6环烷基)CO--、--CONH--、--CON(C.sub.1-4烷基)--、--CON(C.sub.5-6环烷基)--、--NHCONH--、--N(C.sub.5 H.sub.6)CONH--或--N(取代苯基)CONH--、可选择取代苯并咪唑基或可选择取代三环基,以及它们的金属和酸盐。
  • Use of malonic acid derivative compounds for retarding plant growth
    申请人:Rhone-Poulenc Inc.
    公开号:US05292937A1
    公开(公告)日:1994-03-08
    This invention relates to a method for retarding plant growth by applying to the plant an effective amount of a malonic acid derivative compound. This invention also relates to novel malonic acid derivative compounds and processes for the preparation thereof.
    这项发明涉及一种通过向植物施加丙二酸衍生物化合物的有效量来延缓植物生长的方法。该发明还涉及新颖的丙二酸衍生物化合物及其制备方法。
  • Synergistic plant growth regulator compositions
    申请人:Rhone-Poulenc Nederland B.V.
    公开号:US05123951A1
    公开(公告)日:1992-06-23
    This invention relates to synergistic plant growth regulator compositions containing (1) an ethylene response or ethylene-type response inducing agent and (11) a malonic acid derivative compound. This invention also relates to the use of said compositions for inducing synergistic plant growth regulating responses or ethylene responses or ethylene-type responses.
    这项发明涉及含有(1)乙烯响应或类似乙烯响应诱导剂和(11)丙二酸衍生物化合物的协同植物生长调节剂组合物。该发明还涉及利用上述组合物诱导协同植物生长调节响应或乙烯响应或类似乙烯响应。
  • Tunable Copper-Catalyzed Reaction of C<sub>60</sub> with 2-Ethoxycarbonylacetamides and Subsequent BF<sub>3</sub>·Et<sub>2</sub>O-Mediated Isomerization of the Generated Dihydrofuran-Fused Fullerenes to Fulleropyrrolidinones
    作者:Qiaoqiao Teng、Yi-Chen Tan、Chun-Bao Miao、Xiao-Qiang Sun、Hai-Tao Yang
    DOI:10.1021/acs.joc.8b02547
    日期:2018.12.21
    copper-catalyzed reaction of C60 with 2-ethoxycarbonylacetamides using air as the oxidant has been explored, which selectively affords methanofullerenes (2) and dihydrofuran-fused fullerenes (3) under the CuI/DMAP and CuCl/NMI catalytic systems, respectively. Furthermore, the generated dihydrofuran-fused fullerenes could be transformed to fulleropyrrolidinones (4 and 5) upon treatment with BF3·Et2O.
    已经研究了使用空气作为氧化剂的C 60与2-乙氧基羰基乙酰胺的可调谐铜催化反应,该反应分别在CuI / DMAP和CuCl / NMI催化体系下分别提供了甲基富勒烯(2)和二氢呋喃稠合的富勒烯(3)。 。此外,在用BF 3 ·Et 2 O处理后,生成的二氢呋喃稠合的富勒烯可以转化为全吡咯烷酮(4和5)。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐